[KROS] YoY Annual Result on 31-Dec-2023 [#FY]

Stock
[KROS] Keros Therapeutics, Inc.
Announcement Date
30-Dec-2023
Financial Year
2023
Quarter
31-Dec-2023 [#FY]
Profit Trend
YoY- -46.15%
Quarter Report
KROS's Result
KROS's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
Revenue 151 0 20,100 0 10,000 10,000 -56.74%
PBT -152,992 -104,679 -56,733 -45,533 -12,336 -1,078 169.26%
Tax -206 1 2,011 -172 8 257 -
NP -152,992 -104,680 -58,744 -45,361 -12,344 -1,335 157.99%
Tax Rate - - - - - - -
Total Cost 153,143 104,680 78,844 45,361 22,344 11,335 68.27%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
NP Margin -101,319.21 0.00 -292.26 0.00 -123.44 -13.35 496.50%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
EPS -5.20 -4.15 -2.52 -2.93 -1.39 -0.15 103.14%
EPS Diluted -5.20 -4.15 -2.52 -2.93 -1.39 -0.15 103.14%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.